1,375
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

Effect of different dialysis duration on the prognosis of peritoneal dialysis-associated peritonitis: a single-center, retrospective study

ORCID Icon, , , , , , , , , & show all
Article: 2177496 | Received 26 Sep 2022, Accepted 01 Feb 2023, Published online: 14 Feb 2023

References

  • Boudville N, Kemp A, Clayton P, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol. 2012;23(8):1398–1405.
  • Ozisik L, Ozdemir F, Tanriover M. The changing trends of peritoneal dialysis related peritonitis and novel risk factors. Ren Fail. 2015;37(6):1027–1032.
  • Zhao J, Yang L, Zhu X, et al. Clinical characteristics and treatment outcomes of first peritonitis in patients receiving long-term peritoneal dialysis: a multicenter study. Nan Fang Yi Ke Da Xue Xue Bao. 2020;40(12):1740–1746.
  • Li P, Szeto C, Piraino B, et al. ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int. 2016;36(5):481–508.
  • Maitra S, Burkart J, Fine A, et al. Patients on chronic peritoneal dialysis for ten years or more in North america. Perit Dial Int. 2000;20(2_suppl):127–133.
  • Perl J, Fuller D, Bieber B, et al. Peritoneal dialysis-related infection rates and outcomes: results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis. 2020;76(1):42–53.
  • Abdel-Rahman E, Wakeen M, Zimmerman S. Characteristics of long-term peritoneal dialysis survivors: 18 years experience in one center. Perit Dial Int. 1997;17(2):151–156.
  • Kee Y, Park J, Yoon C, et al. Characteristics and clinical outcomes of end-stage renal disease patients on peritoneal dialysis for over 15 years: a Single-Center experience. Perit Dial Int. 2017;37(5):535–541.
  • Wu H-Y, Hung K-Y, Huang T-M, et al. Safety issues of long-term glucose load in patients on peritoneal dialysis–a 7-year cohort study. PLoS One. 2012;7(1):e30337.
  • Krishnan M, Thodis E, Ikonomopoulos D, et al. Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int. 2002;22(5):573–581.
  • Moon S, Han S, Kim D, et al. Risk factors for adverse outcomes after peritonitis-related technique failure. Perit Dial Int. 2008;28(4):352–360.
  • Yang C, Chen T, Lin Y, et al. Determinants of catheter loss following continuous ambulatory peritoneal dialysis peritonitis. Perit Dial Int. 2008;28(4):361–370.
  • Oki R, Tsuji S, Hamasaki Y, et al. Time until treatment initiation is associated with catheter survival in peritoneal dialysis-related peritonitis. Sci Rep. 2021;11(1):6547.
  • Chow K, Szeto C, Cheung K, et al. Predictive value of dialysate cell counts in peritonitis complicating peritoneal dialysis. Clin J Am Soc Nephrol. 2006;1(4):768–773.
  • Meng L, Yang L, Zhu X, et al. Development and validation of a prediction model for the cure of peritoneal dialysis-associated peritonitis: a multicenter observational study. Front Med. 2022;9:875154.
  • Rotellar C, Black J, Winchester J, et al. Ten years’ experience with continuous ambulatory peritoneal dialysis. Am J Kidney Dis. 1991;17(2):158–164.
  • Lupo A, Tarchini R, Carcarini G, et al. Long-term outcome in continuous ambulatory peritoneal dialysis: a 10-year-survey by the Italian cooperative peritoneal dialysis study group. Am J Kidney Dis. 1994;24:826–837.
  • Troidle L, Gorban-Brennan N, Kliger A, et al. Effect of duration of chronic peritoneal dialysis therapy on the development of peritonitis. Perit Dial Int. 1999;19:376–379.
  • Williams J, Craig K, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13(2):470–479.
  • Margetts P, Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int. 2003;23(6):530–541.
  • Bartosova M, Schaefer B, Vondrak K, et al. Peritoneal dialysis vintage and glucose exposure but not peritonitis episodes drive peritoneal membrane transformation during the first years of PD. Front Physiol. 2019;10:356.
  • Ayuzawa N, Ishibashi Y, Takazawa Y, et al. Peritoneal morphology after long-term peritoneal dialysis with biocompatible fluid: recent clinical practice in Japan. Perit Dial Int. 2012;32(2):159–167.
  • Tawada M, Hamada C, Suzuki Y, et al. Effects of long-term treatment with low-GDP, pH-neutral solutions on peritoneal membranes in peritoneal dialysis patients. Clin Exp Nephrol. 2019;23(5):689–699.
  • McGregor S, Topley N, Jörres A, et al. Longitudinal evaluation of peritoneal macrophage function and activation during CAPD: maturity, cytokine synthesis and arachidonic acid metabolism. Kidney Int. 1996;49(2):525–533.
  • Parikova A, Hruba P, Krediet R, et al. Long-term peritoneal dialysis treatment provokes activation of genes related to adaptive immunity. Physiol Res. 2019;68(5):775–783.
  • Nochaiwong S, Ruengorn C, Koyratkoson K, et al. A clinical risk prediction tool for peritonitis-associated treatment failure in peritoneal dialysis patients. Sci Rep. 2018;8:14797.